Factores de riesgo de fractura incidente en pacientes con cáncer de mama tratadas con inhibidores de la aromatasa: cohorte B-ABLE by García-Giralt N, Pineda-Moncusí M, Ovejero D, Aymar I, Soldado-Folgado J, Campodarve I, Rodríguez-Morera J, Nogués X

Get full text

Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index by Nogués, X, Prieto-Alhambra, D, Güerri-Fernández, R, Garcia-Giralt, N, Rodriguez-Morera, J, Cos, L, Mellibovsky, L, Pérez, A

Effect of vitamin D supplementation on aromatase inhibitor-related musculoskeletal side effects for breast cancer: B-ABLE cohort by Pineda-Moncusí, M, Servitja, S, Extebarria Foronda, I, García-Vives, E, Cos, ML, Giménez-Argente, C, Rodríguez-Morera, J, Rial, A, García-Giralt, N, Xavier Nogues, X, Ovejero, D

Calcifediol treatment and COVID-19-related outcomes by Nogues, X, Ovejero, D, Pineda-Moncusí, M, Bouillon, R, Arenas, D, Pascual, J, Ribes, A, Guerri-Fernandez, R, Villar-Garcia, J, Rial, A, Gimenez-Argente, C, Cos, ML, Rodriguez-Morera, J, Campodarve, I, Quesada-Gomez, JM, Garcia-Giralt, N